Indomethacin-responsive headache syndromes

  title={Indomethacin-responsive headache syndromes},
  author={David W. Dodick},
  journal={Current Pain and Headache Reports},
  • D. Dodick
  • Published 1 February 2004
  • Medicine, Psychology
  • Current Pain and Headache Reports
Indomethacin-responsive headache syndromes represent a unique group of primary headache disorders characterized by a prompt and often complete response to indomethacin to the exclusion of other nonsteroidal anti-inflammatory drugs and medications usually effective in treating other primary headache disorders. Because these headache disorders can easily be overlooked in clinical practice, they likely are more common than previously recognized. Indomethacin-responsive headache syndromes can be… 
Can response to indomethacin exclude the diagnosis of cluster headache?
This paper inspires us to re-think the diagnostic criteria of trigeminal autonomic cephalalgias (TACs) in the International Classification of Headache Disorders, 2nd edn (ICHD-2) (2).
Case report of hypnic headache: a rare headache disorder with nocturnal symptoms
An 86-year-old female presented with chronic daily headache of 1 year duration and remains headache free on low dose indomethacin maintenance at 1  year after the diagnosis of hypnic headache, suggesting better understanding of uncommon headache syndromes.
Mechanism of Action of Indomethacin in Indomethacin-Responsive Headaches
The current knowledge of pharmacology, treatment options, and recommendations for the use of indomethacin in primary headaches, as well as new findings from the field of headache research, are summarized.
Update on the diagnosis and management of Trigemino-Autonomic Headaches
  • A. May
  • Medicine, Psychology
    Journal of Neurology
  • 2006
Although TACs are, in comparison with migraine, quite rare, it is nevertheless very important to consider the clinical factor that they are easy to diagnose and the treatment is very effective in most patients.
The “Other” Headaches: Primary Cough, Exertion, Sex, and Primary Stabbing Headaches
Recent large-scaled studies have revealed that the ICHD-II criteria of these four headache disorders cannot be completely fulfilled, and further revisions for the I CHD- II criteria are required based on these results of the evidence-based studies.
New Therapeutic Approach to Primary Stabbing Headache
The case of 5 patients with diagnosis of primary stabbing headache without comorbidity of anxiety or depression that shows a partial response to Indomethacin, but do not respond to Benzodiazepines is described.
Indomethacin‐responsive headaches—A narrative review
The so‐called indomethacin‐responsive headache disorders consist of a group of conditions with a very different presentation that have a particularly good response to indomethin, so distinct as to be used in the definition of two: hemicrania continua and paroxysmal hemic Brania.
Other Primary Headaches: An Update.
Stabbing headache in patients with autoimmune disorders
Management of Headache in the Elderly
The evaluation of the elderly patient with new-onset or recurrent headache requires a grasp of the heterogeneous set of causes of secondary head pain disorders, and knowledge of drug interactions is particularly important as polypharmacy is the rule.


Hypnic Headache: Another Indomethacin‐Responsive Headache Syndrome?
Hypnic headache syndrome appears to represent yet another headache disorder in which there is sometimes an impressive response to indomethacin, and lithium has been reported to be an effective treatment, but the side effects of this medication are sometimes prohibitive.
A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic feature, including new cases.
It is suggested that the short-lasting primary headache syndromes are sufficiently well established for inclusion in the International Headache Society Classification system and that trigeminal-autonomic cephalalgias should be classified as a group together.
Hemicrania continua is not that rare
All cases of chronic unilateral daily headaches should receive an indomethacin trial early if not first in treatment, and hemicrania continua is not a rare disorder.
Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies.
Patients with episodic cluster headache fulfilling the criteria of the International Headache Society were examined during an acute spontaneous attack of headache to determine the local cranial release of neuropeptides to demonstrate in vivo human evidence for activation of the trigeminovascular system and the cranial parasympathetic nervous system.
Hemicrania Continua: An Indomethacin‐Responsive Case With an Underlying Malignant Etiology
A case of indomethacin-responsive hemicrania continua related to an underlying lung neoplasm is described, a potential pathophysiology is proposed, and recommendations for the recognition and management of similar cases are suggested.
The Hypnic (“Alarm Clock”) Headache Syndrome
Hypnic headache syndrome is a rare, sleep-related, benign headache disorder that largely remains unchanged or attenuates over time, but frequency may vary in either direction.
Hemicrania continua
Ten new patients are described and 24 prior reports of hemicrania continua, an uncommon, unilateral headache disorder characterized by a continuous baseline headache of moderate severity with superimposed exacerbations of more severe pain are reviewed.
Neuropeptide Changes in a case of Chronic Paroxysmal Hemicrania—Evidence for Trigemino-Parasympathetic Activation
A patient fulfilling International Headache Society guidelines for the diagnosis of CPH is reported in whom levels of calcitonin gene-related peptide (CGRP) and vasoactive intestinal polypeptide (VIP) were elevated in the cranial circulation during attacks.
Cough, exertional, and sexual headaches
Benign cough headache began significantly later, 43 years on average, than benign exertional headache, and there is a close relationship between benign exertedional headache and benign vascular sexual headache.